BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 11:44:00 AM | Browse: 1015 | Download: 1072
 |
Received |
|
2013-12-18 13:48 |
 |
Peer-Review Started |
|
2013-12-18 16:27 |
 |
To Make the First Decision |
|
2014-01-23 17:20 |
 |
Return for Revision |
|
2014-02-20 22:20 |
 |
Revised |
|
2014-02-22 00:16 |
 |
Second Decision |
|
2014-03-17 14:34 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-03-17 14:45 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-05-07 14:41 |
 |
Publish the Manuscript Online |
|
2014-05-12 18:06 |
Category |
Oncology |
Manuscript Type |
Topic Highlights |
Article Title |
Relationship between head and neck cancer therapy and some genetic endpoints
|
Manuscript Source |
Invited Manuscript |
All Author List |
Eliana Maria Minicucci, Glenda Nicioli da Silva and Daisy Maria Fávero Salvadori |
Funding Agency and Grant Number |
|
Corresponding Author |
Daisy Maria Fávero Salvadori, PhD, Departamento de Patologia, Faculdade de Medicina de Botucatu, Univ. Estadual Paulista, UNESP, Botucatu Distrito de Rubião Júnior, s/nº, Botucatu, SP 18618-000, Brazil. dfavero@fmb.unesp.br |
Key Words |
Chemotherapy; Head and neck cancer; Radiotherapy; Toxicogenetic; Toxicogenomic |
Core Tip |
The main therapies for head and neck cancer (HNC) are surgery, radiotherapy (RT) and chemotherapy. Considering that both RT and chemotherapeutical drugs can interact with the DNA, one of the important, late-occurring complications is a therapy-related secondary tumor resulting from the genotoxic effects of the therapy on the healthy cells. This review presents an update of the toxicogenetic and toxicogenomic effects of HNC treatments, highlighting the main mechanisms evolved in the secondary damage caused by RT and chemotherapies. |
Publish Date |
2014-05-12 18:06 |
Citation |
Minicucci EM, da Silva GN, Salvadori DMF. Relationship between head and neck cancer therapy and some genetic endpoints. World J Clin Oncol 2014; 5(2): 93-102 |
URL |
http://www.wjgnet.com/2218-4333/full/v5/i2/93.htm |
DOI |
http://dx.doi.org/10.5306/wjco.v5.i2.93 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345